NEW YORK (TheStreet) -- CHANGE IN RATINGS
Apple was upgraded at Jefferies to buy from hold. Valuation call, based on a $600 price target, Jefferies said.
Jiayuan.com was upgraded to buy at TheStreet Ratings.
Evercore was downgraded at Goldman Sachs to neutral from buy. Valuation call, based on a $52 price target, Goldman said.
Synageva was downgraded at Wedbush to neutral from outperform. Valuation call, based on a $67 price target, Wedbush said.
Hain Celestial was upgraded at Piper Jaffray to overweight from neutral. $94 price target. Healthy foods should continue to see secular growth, Piper Jaffray said.
HollyFrontier was downgraded at Imperial Capital to in-line from outperform. $41 price target. Estimates also cut, given a contraction in refining margins, Imperial Capital said.
Lazard was upgraded at Goldman Sachs to buy from neutral. Company was also placed on the Conviction Buy list, with a $45 price target. Company should see higher growth and margins across the board, Goldman said.
Piedmont Natural Gas was downgraded to hold at TheStreet Ratings.
Northeast Utilities was initiated with an equal-weight rating at Morgan Stanley. Valuation call, based on a $43 price target, Morgan Stanley said.
Qualcomm was downgraded at Bank of America/Merrill Lynch to neutral from buy. $75 price target. Market dynamics don't bode well for the company's growth, BofA/Merrill said.
Realogy was upgraded at Goldman Sachs to buy. $54 price target. Company should see stabilization in royalty rates and commission splits, Goldman said.
Signet was upgraded at Deutsche Bank to buy from hold. $85 price target. Company can deliver low-teens annual earnings growth over the next three years, Deutsche Bank said.
Toll Brothers was downgraded at Goldman Sachs to neutral. Valuation call, based on a $36.50 price target, Goldman said.
Umpqua was upgraded at Sterne Agee to buy from neutral. Valuation call, based on a $19 price target. Estimates were also increased, as the STSA acquisition should add to earnings, Sterne Agee said.
Worthington was upgraded at Keybanc to buy from hold. $46 price target. Company should continue to generate strong earnings and cash flow, Keybanc said.
Stock Comments / EPS Changes
Affiliated Managers Group estimates were increased at Jefferies through 2014. Earnings power should increase given weak fixed-income returns and seasonal strength, Jefferies said. Buy rating and $214 price target.
Biogen Idec numbers were increased at Leerink Swann. Estimates were raised through 2014. Tecfidera could post higher growth, Leerink Swann said. Outperform rating and new $300 price target.
Facebook estimates, price target were boosted at Topeka. Shares are now seen reaching $60. Estimates were also upped, given stronger advertising trends, Topeka said. Buy rating.
Halliburton estimates, price target were raised at Jefferies. Shares are now seen reaching $58. Estimates were also increased on favorable market environment, Jefferies said. Buy rating.
Schlumberger numbers were raised at Jefferies. Shares are now seen reaching $105. Estimates were also increased on higher momentum in Russia and China, Jefferies said. Buy rating.
>To submit a news tip, email: firstname.lastname@example.org.
Follow TheStreet on Twitter and become a fan on Facebook.
EXCLUSIVE OFFER: See inside Jim Cramer’s multi-million dollar charitable trust portfolio to see the stocks he thinks could be potentially HUGE winners. Click here to see his holdings for FREE.
- Investment & Company Information
- Goldman Sachs